Skip to content

Cadmium Chloride

Cadmium chloride (CdCl₂) is an inorganic compound composed of cadmium and chlorine. It typically appears as a white crystalline solid that is highly soluble in water. As a salt of the heavy metal cadmium, it serves as a common source of cadmium ions in various laboratory experiments and industrial applications. Cadmium itself is a naturally occurring element found in the Earth’s crust.

Cadmium chloride, like other cadmium compounds, exhibits significant toxicity to biological systems. Its harmful effects stem from its ability to interfere with numerous cellular processes. Cadmium ions can bind strongly to sulfhydryl groups within proteins, disrupting the function of essential enzymes and structural proteins. Furthermore, cadmium can mimic and displace vital metal ions such as zinc, calcium, and iron, leading to impaired cellular signaling and metabolic pathways. Exposure to cadmium chloride also triggers oxidative stress, causes damage to DNA, and can induce programmed cell death (apoptosis).

Exposure to cadmium chloride can result in a range of adverse health outcomes. Acute exposure, often through inhalation or ingestion, may cause immediate gastrointestinal distress, respiratory irritation, and acute kidney injury. Chronic exposure, which can occur over prolonged periods, is linked to more severe and long-lasting health problems. These include progressive kidney dysfunction, primarily affecting the renal tubules, and bone demineralization, leading to conditions like osteomalacia and osteoporosis. Cadmium chloride is also recognized as a human carcinogen, increasing the risk of developing cancers of the lung, kidney, and prostate.

The widespread use of cadmium chloride in industrial processes, such as in the manufacturing of batteries, pigments, plastic stabilizers, and in electroplating, contributes to its environmental prevalence. Consequently, human exposure to cadmium is a significant public health concern globally. Primary routes of exposure for the general population include the consumption of contaminated food (particularly shellfish, cereals, and vegetables), polluted drinking water, and inhalation of tobacco smoke. Occupational exposure also remains a risk for workers in industries that handle cadmium. Due to cadmium’s persistent nature in the environment and its long biological half-life in the human body, international regulatory bodies have established strict limits for cadmium levels in food, water, and air to mitigate public health risks.

Methodological and Statistical Constraints

Section titled “Methodological and Statistical Constraints”

Many genome-wide association studies (GWAS) encounter challenges related to statistical power and the potential for spurious findings. Studies with moderate cohort sizes often lack sufficient power to detect modest associations, increasing the risk of false negative results

Genetic variations, such as single nucleotide polymorphisms (SNPs), can influence an individual’s susceptibility to environmental toxins like cadmium chloride by altering gene function in various biological pathways. Several variants are of interest due to their roles in cellular signaling, metabolism, and stress responses. Thers10491442 variant lies within the _PDE4D_ gene, which encodes Phosphodiesterase 4D, an enzyme critical for regulating intracellular cyclic AMP (cAMP) levels. Changes in _PDE4D_activity can impact inflammation, cardiovascular function, and brain health, pathways often disrupted by heavy metal exposure. Similarly,rs7607266 is found in _COMMD1_, a gene involved in copper homeostasis, sodium transport, and the NF-κB inflammatory signaling pathway. Alterations in_COMMD1_ could affect the body’s response to oxidative stress and inflammation induced by cadmium, a known mechanism of toxicity. [1] The rs7867688 variant in _PLPPR1_ (Phospholipid Phosphatase Related 1) is associated with lipid metabolism and neuronal plasticity, suggesting potential implications for cadmium’s neurotoxic effects, as lipid disruption is a common feature of heavy metal exposure. [2]

Other variants impact fundamental cellular processes like division and mitochondrial function, which are sensitive to environmental stressors. The _CDC14A_ gene, harboring the rs17122597 variant, encodes a dual-specificity phosphatase essential for precise cell cycle progression, particularly during mitosis. Disruptions in _CDC14A_ can lead to genomic instability, a hallmark of carcinogenesis, which aligns with cadmium’s known carcinogenic properties. Meanwhile, the rs8021014 variant is located within _COX16_, a gene crucial for the assembly of cytochrome c oxidase, a vital enzyme in the mitochondrial electron transport chain. Impaired mitochondrial function is a primary target of cadmium toxicity, leading to energy depletion and cell damage. [2] Additionally, _TSHZ2_, a zinc finger transcription factor implicated in development, contains the rs6022454 variant. Given cadmium’s ability to displace essential metals like zinc, variants in zinc-binding proteins could modify vulnerability to cadmium-induced developmental or cellular defects. [1]

Variants affecting neuronal integrity and gene regulation also play a significant role in determining individual responses to environmental factors. The _USH2A_ gene, associated with rs114726772 , is critical for the development and maintenance of the inner ear and retina, and mutations can lead to Usher syndrome, a condition of combined hearing and vision loss. While not directly linked to cadmium, heavy metals can impair sensory organ function. _FGF12_, with its rs72607877 variant, encodes an intracellular fibroblast growth factor that modulates neuronal excitability and synaptic transmission. Given cadmium’s well-documented neurotoxicity, variations in _FGF12_ could influence individual susceptibility to cadmium-induced neurological damage. Furthermore, long non-coding RNAs (lncRNAs) like _LINC00607_ (rs72942461 ) and _LINC02462_ (with the rs115347967 variant, near _EEF1A1P35_) are increasingly recognized for their roles in regulating gene expression. These non-coding regions, when altered, can modify the expression of nearby or distant genes, potentially influencing cellular responses to toxic exposures such as cadmium by affecting stress pathways or epigenetic modifications [1]. [2]

RS IDGeneRelated Traits
rs10491442 PDE4Denvironmental exposure measurement
DDT metabolite measurement
cadmium chloride measurement
2,4,5-trichlorophenol measurement
aldrin measurement
rs17122597 CDC14Aenvironmental exposure measurement
chlorpyrifos measurement
cadmium chloride measurement
2,4,5-trichlorophenol measurement
4,6-dinitro-o-cresol measurement
rs114726772 USH2Aenvironmental exposure measurement
chlorpyrifos measurement
DDT metabolite measurement
cadmium chloride measurement
2,4,5-trichlorophenol measurement
rs72607877 FGF12environmental exposure measurement
DDT metabolite measurement
cadmium chloride measurement
2,4,5-trichlorophenol measurement
aldrin measurement
rs8021014 SYNJ2BP-COX16, COX16cadmium chloride measurement
chlorpyrifos measurement
DDT metabolite measurement
2,4,5-trichlorophenol measurement
4,6-dinitro-o-cresol measurement
rs6022454 TSHZ2cadmium chloride measurement
chlorpyrifos measurement
azinphos methyl measurement
2,4,5-trichlorophenol measurement
4,6-dinitro-o-cresol measurement
rs7607266 COMMD1environmental exposure measurement
chlorpyrifos measurement
DDT metabolite measurement
cadmium chloride measurement
4,6-dinitro-o-cresol measurement
rs72942461 LINC00607environmental exposure measurement
DDT metabolite measurement
cadmium chloride measurement
4,6-dinitro-o-cresol measurement
2,4,5-trichlorophenol measurement
rs7867688 PLPPR1lipid measurement
cadmium chloride measurement
chlorpyrifos measurement
DDT metabolite measurement
2,4,5-trichlorophenol measurement
rs115347967 LINC02462 - EEF1A1P35environmental exposure measurement
DDT metabolite measurement
cadmium chloride measurement
2,4,5-trichlorophenol measurement
aldrin measurement

[1] Yang, Q. et al. “Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.”BMC Medical Genetics, vol. 8, 2007, p. S11.

[2] Benyamin, B. et al. “Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.”American Journal of Human Genetics, vol. 84, no. 1, 2009, pp. 60-65.